Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
American Journal of Hematology, 06/29/2012
Clinical Article
Komrokji RS et al. – The findings indicate that hypoalbuminemia is an independent prognostic biomarker that may serve as a surrogate representative of disease biology or co–morbidities in patients with myelodysplastic syndromes (MDS).



